AZILECT vs INBRIJA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Possible drug interaction. AZILECT and INBRIJA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AZILECT	INBRIJA
Rating	56/100	New
Pharmacy pays	~$30.21 /30	—
Type	RX	RX
Active ingredient	RASAGILINE MESYLATE	LEVODOPA
Manufacturer	Teva	Merz
Dosage forms	Tablet	Capsule
Drug class	Monoamine Oxidase Inhibitor	Aromatic Amino Acid
Boxed warning	None	None
Half-life	—	about 50 minutes (extended to about 1.5 hours when taken with carbidopa)
Treats	Parkinson Disease	Parkinson Disease

azilect inbrija

Rating

56/100

New

Pharmacy pays

~$30.21 /30

—

Type

Active ingredient

RASAGILINE MESYLATE

LEVODOPA

Manufacturer

Teva

Merz

Dosage forms

Tablet

Capsule

Drug class

Monoamine Oxidase Inhibitor

Aromatic Amino Acid

Boxed warning

None

Half-life

—

about 50 minutes (extended to about 1.5 hours when taken with carbidopa)

Treats

Parkinson Disease

Frequently asked questions

What is the difference between Azilect and Inbrija?

Azilect contains Rasagiline Mesylate, while Inbrija contains Levodopa — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.